Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SMA
SMA
Novartis buying AveXis for $8.7 billion to strengthen gene therapy capabilities
Stat
Mon, 04/9/18 - 09:00 am
Novartis
M&A
AveXis
gene therapy
AVXS-101
SMA
spinal muscular atrophy
Will 2018 Be Ionis Pharmaceuticals, Inc.'s Best Year Yet?
Motley Fool
Sat, 01/13/18 - 10:43 pm
Ionis Pharmaceuticals
SMA
Spinraza
Biogen, Ionis looking for new SMA drugs following Spinraza's success
BioPharma Dive
Wed, 12/20/17 - 11:05 pm
Biogen
Ionis Pharmaceuticals
SMA
Spinraza
NEJM publishes Phase III results for Biogen/Ionis’ Spinraza
GoinPharma
Mon, 11/6/17 - 08:56 am
Biogen
Ionis Pharmaceuticals
Spinraza
clinical trials
spinal muscular atrophy
SMA
Spinraza launch set for blockbuster trajectory
BioPharma Dive
Wed, 07/26/17 - 12:11 am
Spinraza
Biogen
SMA
spinal muscular atrophy
For Biogen's Spinraza launch, things are looking up on the coverage front: analyst
Fierce Pharma
Thu, 07/20/17 - 10:11 am
Biogen
Spinraza
drug launches
spinal muscular atrophy
SMA
PTC and Roche report solid data for Spinraza rival
BioPharma Dive
Wed, 07/5/17 - 06:55 pm
PTC Therapeutics
Roche
Spinraza
Biogen
RG7916
SMA
spinal muscular atrophy
Biogen’s Spinraza Witnessed Robust Patient Demand in 1Q17
Market Realist
Fri, 04/28/17 - 11:45 am
Biogen
Spinraza
patients
SMA
spinal muscular atrophy
Hyde Park boy with rare disease wins appeal, will receive Biogen drug
Bizjournals.com
Wed, 04/26/17 - 09:35 pm
Biogen
Spinraza
SMA
spinal muscular atrophy
Biogen touts stronger-than-expected rollout for Spinraza
BioPharma Dive
Wed, 04/26/17 - 10:58 am
Biogen
Spinraza
drug launches
SMA
spinal muscular atrophy
Did Biogen Inc. Shoot Itself in the Foot?
Motley Fool
Tue, 02/21/17 - 11:11 am
Biogen
drug pricing
Spinraza
SMA
spinal muscular atrophy
Biogen's latest drug may be costly, but new data suggests it saves lives
Bizjournals.com
Sat, 01/14/17 - 03:37 pm
Biogen
Spinraza
SMA
spinal muscular atrophy
Is Spinraza worth $750K? Biogen says yes, spelling out reduced death risk
Endpoints
Fri, 01/13/17 - 09:41 am
Biogen
Spinraza
SMA
spinal muscular atrophy
Biogen Submits NDA for SMA Drug (BIIB, IONS)
Investopedia
Thu, 09/29/16 - 08:12 am
Biogen
SMA
spinal muscular atrophy
Ionis Pharmaceuticals
Nusinersen
Will MS Franchise & New Drugs Come To Biogen Rescue?
Bidness, ETC
Wed, 09/7/16 - 08:10 pm
Biogen
MS
multiple sclerosis
Nusinersen
SMA
aducanumab
Alzheimer's disease
Infants with rare cases of SMA get stronger, live longer on Isis drug
Fierce Biotech
Thu, 06/11/15 - 10:44 am
SMA
spinal muscular atrophy
Isis Pharmaceuticals
ISIS-SMNRx
Pfizer backs out of development deal with Repligen
Seeking Alpha
Fri, 01/30/15 - 01:18 pm
Pfizer
Repligen
SMA
spinal muscular atrophy
Isis Pharmaceuticals initiates clinical study of ISIS-SMN Rx in infants with SMA
Yahoo/Fly on the Wall
Tue, 04/23/13 - 10:46 am
ISIS-SMN
Isis Pharmaceuticals
spinal muscular atrophy
SMA
Pages
« first
‹ previous
1
2
3
4
5